ARCHIVES

FDA Official Outlines agency’s Views On Efficacy Requirement

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Taking on question of cost and outcomes, CMS turns to expert in cancer care quality.

June 3, 2005

NCI Cooperative Group Clinical Trials Approved

September 24, 2010

Targeting One Specific Protein Can Double PFS; Triple Overall Survival

May 27, 2011

NCI Cooperative Group, Cancer Center Trials Listed

December 26, 2008

NCI Grant To Help Pitt Include Teaching End-of-Life Issues.

July 6, 2001

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

January 13, 1995